Malaysia has widened its medical tourism campaign in Bangladesh, using the Dhaka Travel Mart 2026 and a linked sales mission to Chattogram to court the South Asian market, Bangladesh Post reported. The drive sits inside the wider Visit Malaysia 2026 campaign, and the run of events it anchored was staged from 6 to 11 April 2026. Malaysia presented itself as a healthcare destination for Bangladeshi patients rather than only a holiday market, with medical tourism named as one of the segments it most wants to grow across the region.
Malaysia’s medical tourism pitch at Dhaka Travel Mart 2026
This was Malaysia’s fourteenth consecutive appearance at the Dhaka Travel Mart, a fair that has run since 2002, and the delegation was led by Solehuddin Ahmad, Deputy Director of the International Promotion Division for Asia and Africa, Bangladesh Post reported. The team reached well beyond the usual travel trade, and it carried the Malaysia Healthcare Travel Council, the government agency that promotes the country as a healthcare destination, alongside Education Malaysia Global Services, tour operators and major airlines. Mohd Amirul Rizal Abd Rahim, Director-General of Tourism Malaysia, said that “Bangladesh remains an important market for Malaysia”, tying the presence to the aims of Visit Malaysia 2026 and to closer work with the local tourism trade.
The mix of agencies gives the Dhaka pitch its weight. A tourism board that arrives with a healthcare-travel agency and an education agency in tow is not selling a beach holiday alone, it is selling treatment, study, and the longer, higher-value stays that both of those tend to generate. That intent has held for over a decade. Bangladesh Post reported the presence has been unbroken since 2002.
Medical tourism inside a wider tourism offer
Malaysia is broadening its tourism offer to meet demand for more varied travel, and Bangladesh Post reported that medical tourism now sits alongside educational tourism and eco-tourism in the mix taken to Bangladesh and the wider South Asian region. Medical tourism belongs at the clinical end of the health tourism spectrum, where care is delivered in hospitals and accredited clinics and the decision to travel turns on cost, waiting times and access. The setting decides the category. The clinical end of medical tourism spans diagnostics, orthopaedics, oncology, dermatology and reconstructive surgery, and destinations compete on price and on access across these specialities. Bangladeshi patients who choose Malaysia weigh the familiar drivers of medical travel, better care, faster treatment, or a procedure that is cheaper or simply unavailable at home, and much of that work is elective rather than urgent. That places the medical tourism pitch in a different register from the resort marketing beside it, because a healthcare destination is judged on clinical outcomes and patient safety rather than on scenery.
Bangladesh arrivals and the numbers behind the push
The scale of the opportunity shows in the arrivals data, Bangladesh Post reported. Malaysia welcomed 42,196,892 international visitor arrivals in 2025, and 281,492 of those came from Bangladesh, a rise of 82.1 per cent year on year. That surge is why Malaysia returns to Dhaka. A source market growing more than 80 per cent in a single year is worth defending with a dedicated healthcare-travel agency on the ground, and it explains the fourteen-year commitment. The risk on the other side of that growth is concentration, because a destination that leans on one fast-rising source market inherits the volatility of that market, and its medical tourism corridors are only ever as steady as the demand feeding them. Diversifying the source mix, and the facilitators serving it, is the harder and more durable work.
Air connectivity as the medical travel corridor
Air links are the quiet precondition for any medical tourism corridor, and the Dhaka-to-Malaysia route is already dense, Bangladesh Post reported. There are 41 direct weekly flights connecting Dhaka and Malaysia, offering about 11,340 seats, and they are flown by Malaysia Airlines, Batik Air, AirAsia, Biman Bangladesh Airlines and US-Bangla Airlines. That capacity matters more for patients than holidaymakers. International patients travel on fixed clinical schedules, they often fly with a companion, and they may need to return for follow-up, so frequent and reliable routes lower the friction that can otherwise stall a referral. The connectivity is a genuine asset for the medical tourism pitch, and it is the part of the offer Malaysia shapes least through marketing and most through the airlines that fly the route.
Business sessions and the Chattogram sales mission
The programme paired the Dhaka fair with a sales mission to Chattogram, Bangladesh’s main port city, extending the campaign beyond the capital, Bangladesh Post reported. Business-to-business sessions ran through the Dhaka Travel Mart, giving Malaysian operators and their Bangladeshi partners the room to build the referral relationships that medical tourism depends on. Those meetings are where the healthcare-travel agency earns its place, because a hospital group or a facilitator that signs a Bangladeshi partner gains a channel that outlasts any single fair. The work is cumulative. A fourteen-year presence at the Dhaka Travel Mart reads as strategy rather than habit.
Visit Malaysia 2026 and the destination it is building
Visit Malaysia 2026 is the frame around all of this. Bangladesh Post reported that the campaign is pitched as sustainable tourism aligned with the United Nations Sustainable Development Goals, with aims that run from showcasing natural attractions and cultural heritage to driving inclusive growth and long-term value for local communities. Tourism Malaysia, formally the Malaysia Tourism Promotion Board, carries the campaign under the Ministry of Tourism, Arts and Culture Malaysia. For medical tourism the useful test is narrower than the campaign language around it. A healthcare destination stands or falls on the dull machinery beneath the brand. The brand is the easy part. The accreditation, the clinical outcomes, the aftercare and the ease of securing a visa and a bed are what decide it, and that machinery is what turns an 82.1 per cent arrivals rise into repeat medical travel rather than a single strong year in the data.
